The Recombinant Cell Culture Supplements Market To Get On To Magnanimous mode
Posted by Tanvi Birajdar on March 24th, 2021
Adoption of recombinant cell culture supplements by biopharmaceutical manufacturers and research institutes has increased significantly for the development of novel drugs and treatment. Growing demand for novel vaccines to treat and prevent severe diseases, as well as increasing stem cell research activities by biopharmaceutical manufactures are likely to pace up the lucrativeness of the global recombinant cell culture supplements market.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/31310
Recombinant cell culture supplements are gaining higher adoption in mammalian cell production processes in different production units and research centres. Moreover, rising investments in biologics production and growing research for the introduction of innovative gene therapies are bolstering the demand for recombinant cell culture supplements.
The global recombinant cell culture supplements market was valued around US$ 320 Mn in 2018, and is expected to exhibit a CAGR of more than 6% over the forecast period (2019–2029).
Key Takeaways of Recombinant Cell Culture Supplements Market Study
“Increasing requirement of recombinant cell culture supplements for mammalian cell lines and viral & protein-based vaccines production is likely to pace up market growth. Demand will continue to pick pace, with burgeoning use of supplements in cancer research, tissue regeneration, and gene therapy development,” says a PMR analyst.
Product Portfolio Expansion through Acquisitions & Partnerships – Key Strategy of Manufacturers
Recombinant cell culture supplement manufacturers are focusing on product portfolio expansion through partnerships and acquisition of small. In 2015, Abcam Plc signed an exclusive partnership agreement with A* STAR’s Institute of Molecular and Cell Biology to develop high-quality immunoassays for life science research.
More Valuable Insights on Recombinant Cell Culture Supplements Market
Persistence Market Research offers a unique perspective and actionable insights on recombinant cell culture supplements in its latest study, presenting historical demand assessment of 2014–2018 and projections for 2019–2029, on the basis of product (recombinant growth factors, recombinant insulin, recombinant albumin, recombinant transferrin, recombinant trypsin, recombinant aprotinin, recombinant lysozyme, and others), application (stem cell therapy, gene therapy, bioprocess application, vaccine development, and others), source (animals, microorganisms, and humans), and end user (academic and research institutes, biopharmaceutical companies, cancer research centers, and contract research centers), across seven major regions.
Like it? Share it!
About the AuthorTanvi Birajdar
Joined: November 23rd, 2020
Articles Posted: 28
More by this author